Global Pharma Demand Index — April 2026
In April 2026, the most-requested pharmaceutical product on the PharmaTradz global B2B marketplace was Givosiran Infusion 2.5 mg/kg IV infusion with 3 RFQs, followed by Tirzepatide 40mg Pen device with Cartridge Box (R&D Only) 40 mg and GHK-Cu 100mg Pen device with Cartridge Box (R&D Only) 100 mg. Rankings are compiled from live buyer RFQs, RFP submissions and API sourcing requests across 4 qualifying molecules.
Published 1 May 2026 · Source: PharmaTradz proprietary RFQ data · Molecules with fewer than 2 requests are excluded to protect buyer confidentiality.
| # | Molecule / product | RFQs | vs previous month |
|---|---|---|---|
| 1 | Givosiran Infusion 2.5 mg/kg IV infusion | 3 | New entry |
| 2 | Tirzepatide 40mg Pen device with Cartridge Box (R&D Only) 40 mg | 2 | New entry |
| 3 | GHK-Cu 100mg Pen device with Cartridge Box (R&D Only) 100 mg | 2 | New entry |
| 4 | Tirzepatide 2.5 mg / 0.5 mL, 5 mg / 0.5 mL | 2 | New entry |
Previous editions
June 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025
